ArticleFrontiers in bioengineering and biotechnology2025
Hydrogen improves the efficacy of tetrandrine in the treatment of silicosis by inhibiting vascular endothelial mesenchymal transition caused by oxidative stress.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Silicosis, a lung disease associated with occupational exposure. Tetrandrine has been approved for the treatment of silicosis in China, but it still cannot be cured. This study aims to investigate the reasons behind the low concentration of tetrandrine (Tet) in lung tissue and propose a treatment plan. Methods: We first established a silicosis mouse and employed a combination of histological examination, Western blot analysis, immunofluorescence, and single-cell RNA sequencing to clarify the relationship between oxidative stress vascular endothelial mesenchymal transition (EndMT), and Tet concentration in lung tissue. Results: The study indicated that there is excessive activation of OS and EndMT in silicosis while concurrently reducing Tet concentration in lung tissue (from 94.8 ± 10.4 ng/mg to 54 ± 6.2 ng/mg). Furthermore, combined inhalation of hydrogen (H Conclusion: Hydrogen can improve the tissue concentration of tetrandrine by anti-OS-induced EndMT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.